Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Strong Buy

Analyst Rating

Buy

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Fortrea Holdings Inc. Common Stock (FTRE)

Services-medical Laboratories

https://www.fortrea.com

Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after LabCorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

8 MOORE DRIVE
DURHAM, NC

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

06/16/2023

Market Cap

1,995,392,000

Shares Outstanding

88,800,000

Weighted SO

88,800,000

Total Employees

N/A

Upcoming Earnings

08/12/2024

Similar Tickers

Beta

0.0000

Last Div

0.0000

Range

18.07-41.02

Chg

-0.1500

Avg Vol

1510967

Mkt Cap

1995392000

Exch

NASDAQ

Country

US

Phone

(480)-295-7600

DCF Diff

-51.8772

DCF

78.3772

Div Yield

0.0000

P/S

0.6937

EV Multiple

63.3462

P/FV

1.3626

Div Yield %

0.0000

P/E

-7.5045

PEG

-1.1160

Payout

0.0000

Current Ratio

1.1852

Quick Ratio

1.1852

Cash Ratio

0.1685

DSO

80.9490

DIO

0.0000

Op Cycle

80.9490

DPO

21.8948

CCC

59.0541

Gross Margin

0.1642

Op Margin

-0.0259

Pretax Margin

-0.0776

Net Margin

-0.0922

Eff Tax Rate

-0.0224

ROA

-0.0744

ROE

-0.1636

ROCE

-0.0265

NI/EBT

1.1886

EBT/EBIT

2.9920

EBIT/Rev

-0.0259

Debt Ratio

0.3190

D/E

0.7784

LT Debt/Cap

0.4348

Total Debt/Cap

0.4377

Int Coverage

-1.2818

CF/Debt

0.1217

Equity Multi

2.4402

Rec Turnover

4.5090

Pay Turnover

16.6706

Inv Turnover

0.0000

FA Turnover

16.6164

Asset Turnover

0.8067

OCF/Share

1.5481

FCF/Share

1.1745

Cash/Share

1.4116

OCF/Sales

0.0481

FCF/OCF

0.7587

CF Coverage

0.1217

ST Coverage

10.2519

CapEx Coverage

4.1437

Div&CapEx Cov

4.1437

P/BV

1.3626

P/B

1.3626

P/S

0.6937

P/E

-7.5045

P/FCF

19.0037

P/OCF

14.3854

P/CF

14.3854

PEG

-1.1160

P/S

0.6937

EV Multiple

63.3462

P/FV

1.3626

DPS

0.0000

Latest Headlines (EST)

GlobeNewswire Inc. Jul 19, 23:05 FTRE DEADLINE ALERT: ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Fortrea Holdings, Inc. Investors to Secure Counsel Before Important August 1 Deadline in Securities Class Action – FTRE GlobeNewswire Inc. Jul 17, 02:53 ???? ????? ?????? ???  FTRE: ????, ???? ????? ??? ?????, ????? ??????? ?- Fortrea Holdings, Inc.  ?? ?????? ?? ???? ?- 100 ??? ????, ?????? ????? ???? ????? ?????? ????? ?????? ??????? ??????? ??? – FTRE GlobeNewswire Inc. Jul 12, 19:01 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Red Cat, Organon, UroGen and Fortrea and Encourages Investors to Contact the Firm GlobeNewswire Inc. Jul 11, 18:45 ROSEN, LEADING TRIAL ATTORNEYS, Encourages Fortrea Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – FTRE GlobeNewswire Inc. Jul 08, 01:00 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Red Cat, Reckitt, UroGen and Fortrea and Encourages Investors to Contact the Firm GlobeNewswire Inc. Jul 01, 01:00 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Red Cat, Reckitt, UroGen and Fortrea and Encourages Investors to Contact the Firm GlobeNewswire Inc. Jun 24, 01:00 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Red Cat, Reckitt, UroGen and Fortrea and Encourages Investors to Contact the Firm GlobeNewswire Inc. Jun 24, 00:41 Fortrea Holdings Inc. Stockholders Should Contact Robbins LLP for Information About the Securities Fraud Class Action Pending Against FTRE GlobeNewswire Inc. Jun 22, 18:16 ROSEN, A HIGHLY RANKED LAW FIRM, Encourages Fortrea Holdings, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – FTRE GlobeNewswire Inc. Jun 22, 13:33 FTRE FRAUD ALERT: Fortrea Holdings Inc. Investors are Reminded of Ongoing Securities Fraud Class Action -- Contact BFA Law by August 1 Legal Deadline (NASDAQ:FTRE) GlobeNewswire Inc. Jun 17, 01:00 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Red Cat, Reckitt, UroGen and Fortrea and Encourages Investors to Contact the Firm GlobeNewswire Inc. Jun 14, 11:48 FTRE SHAREHOLDERS: Fortrea Holdings Inc. Investors are Reminded of the Pending Securities Fraud Class Action – Contact BFA Law by August 1 Deadline (NASDAQ:FTRE) GlobeNewswire Inc. Jun 12, 21:44 SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Fortrea GlobeNewswire Inc. Jun 12, 01:11 Class Action Filed: Fortrea Holdings Inc. Investors with Losses Urged to Contact Johnson Fistel GlobeNewswire Inc. Jun 10, 01:00 Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Red Cat and Fortrea and Encourages Investors to Contact the Firm GlobeNewswire Inc. Jun 07, 00:00 FTRE Investor Notice: Stockholder Rights Law Firm Robbins LLP Reminds Shareholders of the Class Action Against Fortrea Holdings, Inc. GlobeNewswire Inc. Oct 17, 23:43 ?????? (Fortrea)????????????????? GlobeNewswire Inc. Oct 17, 23:43 Fortrea ???????????? GlobeNewswire Inc. Oct 17, 23:43 Fortrea publie son premier rapport de Responsabilité Sociale d’Entreprise GlobeNewswire Inc. Oct 17, 23:43 Fortrea ?? ??? ?? ??? ?? (CSR) ??? ??

Revenue Product Segmentation